#drugdevelopment search results
For the first time, scientists used generative AI to create antibodies that successfully bound to real cancer proteins. Is this ๐๐ต๐ฒ ๐ณ๐๐๐๐ฟ๐ฒ ๐ผ๐ณ ๐ฑ๐ฟ๐๐ด ๐ฑ๐ฒ๐๐ฒ๐น๐ผ๐ฝ๐บ๐ฒ๐ป๐? #AI #DrugDevelopment #FutureZone
#ESMO2025 Berlin is SOON here ๐ฉ๐ช ๐ My #Top10 for #drugdevelopment @myESMO Interesting new drugs coming out ๐๐ฝ ๐งซ CAR-T ๐ ADC ๐ฆ Vaccines ๐งช New#ICIs ๐ฏ #therapies @ASCO @_SEOM @VHIO @MDAndersonNews @OncBrothers ๐ Follow: #OncoAlertAF @OncoAlert What do you think? ๐ญ๐๐ฝ
โ๏ธPrediction for #DrugDevelopment: Companies that wait to work on #LongCovid will regret it. This is a large & growing population (w/ very organized/engaged patient #advocacy, major unmet need, & no approved agents) whose disability has huge societal economic impact. Donโt wait.
For over 10 years, we have made #DrugDiscovery & development steps faster & more predictable. Using what weโve learned, we create educational resources to share this information with the #TranslationalScience community. To improve understanding of the complex #DrugDevelopment &โฆ
Totally agree @curijoey - taking a post-#ESMO25 recovery pause in your beautiful home country ๐ฎ๐น ๐ท๐ซโช๏ธ at the momentโฆ before return to #drugdevelopment rat race! ๐ฆ๐บ
Sometimes you just need to pause. Not because youโre lost, but because even the brightest path becomes clearer when you take a moment to breathe and reflect. ๐ฟ
GI toxicity is a major side effect of cancer therapies. Our 3D Colon Organoid Model brings human relevance + high-throughput screening to better predict drug-induced GI toxicity. Explore our poster ๐ shorturl.at/8APaR #Toxicology #Organoids #DrugDevelopment #Innovation
#Oncology #drugdevelopment is a wonderful journey. This cannot be done without #likeminded and #collaborative colleagues from around the World. There are only a few compounds that I've been involved in from the very beginning - #sevabertinib, together with #selpercatinib are 2โฆ
$2.3B. Thatโs the median cost to bring a drug to market. Smart decisions on program continuation, resource allocation, and stakeholder alignment are key to advancing the most promising treatments: bit.ly/4nTAF8V #PremierResearch #ProgramStrategy #DrugDevelopment
Every stage of drug development benefits from the right expertise. Explore how choosing between a CDMO, CMO, or CRO can define your projectโs progress in our new blog. Read the full article here: hubs.la/Q03Q9lx-0 #NeulandLabs #CDMO #DrugDevelopment #Outsourcing
Is CRBP stock just practicing its yoga poses with all these ups and downs? Source: finquota.com/CRBP/ #StockMarket #DrugDevelopment #ClinicalTrials #NYSE #stock #stocks
#ESMO25 ๐จ FIRST of my #Top10 #drugdevelopment ๐๐ฝ EVX-01 (vaccine) + Pembro ๐ฃ๏ธ @AdnanKhattakOnc ๐ฅ Melanoma r/R PD-1/PD-L1 โ๏ธ ORR 75% w/92% sustained response at 24mโ โ 81% vaccine neoantigens โ 100% vaccine induced T cells โฃ๏ธ โ Missing #tox @OncoAlert @myESMO @_SEOM @ASCO
Can human mini-Hearts advance cardiovascular drug development? ddw-online.com/how-human-miniโฆ Follow DDW; Business insights for the global scientific community #DrugDevelopment
#BioFuture2025 Day 3 spotlighted innovation at every level, from The New Policy Landscape to #AI in #DrugDevelopment. Thank you to our speakers, sponsors, and attendees for an incredible close to this yearโs conference. See you in 2026! ๐ซ
#ESMO25 #drugdevelopment ๐๐ฝ Botensilimab (CTLA4) + Balstilimab (PD1) ๐ฃ๏ธ Dr. Gordon ๐ฅ Pantumor cold tumors and PD1 r/r โ ORR 17% โ 411 patients โ Durable responses in ๐ฅถtumors โฃ๏ธ 10% =>G3 colitis @OncoAlert @myESMO @_SEOM @ASCO
Prof Loong with an engaging talk on patient selection-genomic matching, handling NGS big data, and considering intratumoural heterogeneity - Day 1 @myesmo Advanced Course on #DrugDevelopment in Hong Kong / session chaired by Prof Jayesh Desai & Prof Brigette Ma
With 200+ years of combined expertise, Certaraโs Simcyp team leads the way in PBPK scienceโdriving 125+ FDA approvals, EMA qualification, and global regulatory trust. See how Simcyp accelerates safer, smarter drug development: ow.ly/yVsu50X85I6 #PBPK #DrugDevelopment
AI is beginning to reshape the early stages of drug development, with the first AI-designed drugs expected to reach regulatory approval by 2030. Read this @pharmaphorum article to learn about the real value AI provides to drug developers: #drugdevelopment #AI #digital #pharma
Join us in Paris on October 8 for a one-day deep dive into the future of early-stage drug development. You'll hear directly from leading VCs about what drives funding decisions in todayโs market! ๐ Register here: ow.ly/xnai50X1A2y #DrugDevelopment #SoftgelTechnology
Timely delivery of clinical supplies & equipment to sites is crucial for any clinical trial [email protected] #drugdiscovery #drugdevelopment #studystartup #clinicaltrials #healthcare #clinicalresearch #patientrecruitment #sitemanagement #clinicaldevelopment
Intrinseque Health offers customised storage solutions for supplies required to conduct clinical trials. [email protected] #drugdiscovery #drugdevelopment #studystartup #clinicaltrials #healthcare #clinicalresearch #patientrecruitment #sitemanagement
๐Join the Global Congress on Pharma Research and Drug Development! ๐ Tokyo, Japan ๐๏ธApril 16โ17, 2026 ๐ฒScan the QR code on the banner to secure your slot instantly #PharmaCon2026 #DrugDevelopment #PharmaResearch #ClinicalTrials #TokyoEvents #PharmaceuticalScience #SciMeetHub
Transporting biospecimens not only requires strict temperature controls, but also global regulatory adherence and customs handling expertise [email protected] #drugdiscovery #drugdevelopment #studystartup #clinicaltrials #healthcare #clinicalresearch
In 2025, C-Path proudly celebrates 20 years of impact. Take a look back at the highlights and the incredible individuals who made it all possible. Here's to the next chapter of innovation! f.mtr.cool/crpohtxhxb #CPath20Years #DrugDevelopment #Collaboration
Success in biotech requires navigating four distinct paths: scientific, regulatory, commercial, and reimbursement. A weakness in any one of them can derail even the best science. #Biotech #Strategy #DrugDevelopment
While oncology is still a powerhouse, other areas like metabolic diseases, rare genetic conditions, and gene therapy are rapidly gaining ground. #DrugDevelopment #GeneTherapy #Oncology
Dive into the world of #drugdevelopment w/ C-Path's #YouTube channel! Subscribe now for access to on-demand content including meetings, webinars, interviews, and more. Stay informed, stay inspired! Subscribe here: f.mtr.cool/dciojufrgn
$2.3B. Thatโs the median cost to bring a drug to market. Smart decisions on program continuation, resource allocation, and stakeholder alignment are key to advancing the most promising treatments: bit.ly/4nTAF8V #PremierResearch #ProgramStrategy #DrugDevelopment
For the first time, scientists used generative AI to create antibodies that successfully bound to real cancer proteins. Is this ๐๐ต๐ฒ ๐ณ๐๐๐๐ฟ๐ฒ ๐ผ๐ณ ๐ฑ๐ฟ๐๐ด ๐ฑ๐ฒ๐๐ฒ๐น๐ผ๐ฝ๐บ๐ฒ๐ป๐? #AI #DrugDevelopment #FutureZone
The @MHRAgovuk has released a policy paper on rare therapies and regulatory considerations. Meet our team of experts and book an introductory call today: scendea.com/contact - #RareDiseaseTherapies #drugdevelopment #UKregulatoryconsiderations
Partner with Aurigene for cutting-edge formulation services that accelerate your journey from concept to clinic. ๐ฉ Letโs connect and explore how we can help bring your vision to life! #PharmaceuticalServices #DrugDevelopment #FormulationScience #Innovation #Aurigene
With a specific emphasis on clinical trials, Intrinseque Health provides a high level of expertise for each clinical supply chain plan. [email protected] #drugdiscovery #drugdevelopment #studystartup #clinicaltrials #healthcare #clinicalresearch #patientrecruitment
Get ready to discover how Aurigene.Ai, a multi-agentic, multimodal platform, is redefining the โfail fast, iterate fasterโ paradigm in drug discovery!! ๐ง ๐บ๐๐๐ ๐๐๐๐๐ ๐๐ ๐๐๐๐๐ ๐๐๐ ๐๐๐๐ ๐๐๐๐๐๐ ๐ #DrugDevelopment #Aurigene #CRO
Q4 2025 PitchBook Analyst Note: #AI in #DrugDevelopment | PitchBook pitchbook.com/news/reports/qโฆ
Letโs Plan Aheadโฆ.and not miss a single study timeline due to delays in clinical supplies and equipment reaching sites on time. [email protected] #drugdiscovery #drugdevelopment #studystartup #clinicaltrials #healthcare #clinicalresearch #patientrecruitment
For the first time, scientists used generative AI to create antibodies that successfully bound to real cancer proteins. Is this ๐๐ต๐ฒ ๐ณ๐๐๐๐ฟ๐ฒ ๐ผ๐ณ ๐ฑ๐ฟ๐๐ด ๐ฑ๐ฒ๐๐ฒ๐น๐ผ๐ฝ๐บ๐ฒ๐ป๐? #AI #DrugDevelopment #FutureZone
Is CRBP stock just practicing its yoga poses with all these ups and downs? Source: finquota.com/CRBP/ #StockMarket #DrugDevelopment #ClinicalTrials #NYSE #stock #stocks
#ESMO2025 Berlin is SOON here ๐ฉ๐ช ๐ My #Top10 for #drugdevelopment @myESMO Interesting new drugs coming out ๐๐ฝ ๐งซ CAR-T ๐ ADC ๐ฆ Vaccines ๐งช New#ICIs ๐ฏ #therapies @ASCO @_SEOM @VHIO @MDAndersonNews @OncBrothers ๐ Follow: #OncoAlertAF @OncoAlert What do you think? ๐ญ๐๐ฝ
For over 10 years, we have made #DrugDiscovery & development steps faster & more predictable. Using what weโve learned, we create educational resources to share this information with the #TranslationalScience community. To improve understanding of the complex #DrugDevelopment &โฆ
GI toxicity is a major side effect of cancer therapies. Our 3D Colon Organoid Model brings human relevance + high-throughput screening to better predict drug-induced GI toxicity. Explore our poster ๐ shorturl.at/8APaR #Toxicology #Organoids #DrugDevelopment #Innovation
Can human mini-Hearts advance cardiovascular drug development? ddw-online.com/how-human-miniโฆ Follow DDW; Business insights for the global scientific community #DrugDevelopment
AI is beginning to reshape the early stages of drug development, with the first AI-designed drugs expected to reach regulatory approval by 2030. Read this @pharmaphorum article to learn about the real value AI provides to drug developers: #drugdevelopment #AI #digital #pharma
Final call: Dr. George Church will be speaking about how DNA sequencing is becoming more accessible, transforming #drugdevelopment for #precisionmedicine. Join our next Genomics for Health webinar tomorrow ๐ event.on24.com/wcc/r/5025154/โฆ
Join us in Frankfurt as our experts share how cutting-edge science, automation, and advanced platforms are transforming development and supply! ๐ Schedule a 1:1 meeting with our team and explore whatโs next for your mission: ow.ly/6SY050Xgji2 #CPHI2025 #DrugDevelopment
#Oncology #drugdevelopment is a wonderful journey. This cannot be done without #likeminded and #collaborative colleagues from around the World. There are only a few compounds that I've been involved in from the very beginning - #sevabertinib, together with #selpercatinib are 2โฆ
Engaging Discussion - @VivekSubbiah oncodaily.com/blog/vivek-subโฆ @SaheliSadanand #EngagingDiscussion #PrecisionMedicine #DrugDevelopment #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews
Thank you to everyone who attended our recent seminar in Copenhagen! We had an incredible time connecting with innovators across the life sciences community to explore strategies for de-risking emerging new chemical modalities. #MVA #DrugDevelopment #PharmaInnovation
#ESMO25 ๐จ FIRST of my #Top10 #drugdevelopment ๐๐ฝ EVX-01 (vaccine) + Pembro ๐ฃ๏ธ @AdnanKhattakOnc ๐ฅ Melanoma r/R PD-1/PD-L1 โ๏ธ ORR 75% w/92% sustained response at 24mโ โ 81% vaccine neoantigens โ 100% vaccine induced T cells โฃ๏ธ โ Missing #tox @OncoAlert @myESMO @_SEOM @ASCO
BioNxt has launched a 15-day dosing optimisation study for its sublingual multiple sclerosis (MS) drug, marking the final step before human bioequivalence testing planned for early 2026. ๐ Full story: buff.ly/gPjwCF7 #MultipleSclerosis #NeuroResearch #DrugDevelopmentโฆ
Recent advances have immense potential to streamline and democratize #DrugDiscovery. Learn about a new computationally driven platform for #DrugDevelopment that combines #physics and #DeepLearning methods at our May 15 webinar: ow.ly/Tcvf50VRoPO
In our #ReadoftheMonth, we take a deep dive into the GLP-1 phenomenon ๐ With remarkable successes come inevitable hurdles. Find out what more experts had to say about GLP-1 drug development during an AAPS workshop. ๐ ow.ly/h4OQ50Xg8tE #GLP1 #DrugDevelopment
โShow me the data.โ ๐ Thatโs what investors want. Learn how MIDD helps prove value, de-risk decisions & strengthen negotiations. US Nov 6 | EMEA Nov 13 | APAC Nov 20 Register ๐ ow.ly/JzYc50XaNgx #MIDD #Biotech #DrugDevelopment
What an incredible week at #CPHIFrankfurt! A huge thank-you to everyone who joined our sessions. Together, weโre advancing the future of smarter pharma solutions. ๐๐ #AtTheHeartOfPharma #DrugDevelopment
Prof Loong with an engaging talk on patient selection-genomic matching, handling NGS big data, and considering intratumoural heterogeneity - Day 1 @myesmo Advanced Course on #DrugDevelopment in Hong Kong / session chaired by Prof Jayesh Desai & Prof Brigette Ma
While there is substantial investment in #DrugDevelopment in the U.S., our new report finds that how research is prioritized doesn't systematically account for disease burden and unmet needs โ often leaving critical gaps in treatment options. Learn more: ow.ly/Ra8250Wq6CP
Something went wrong.
Something went wrong.
United States Trends
- 1. Massie 89.5K posts
- 2. #Varanasi 137K posts
- 3. #CollegeGameDay 1,778 posts
- 4. Good Saturday 34.8K posts
- 5. Lawson Luckie N/A
- 6. #MeAndTheeSeriesEP1 1.29M posts
- 7. Willie Green 4,579 posts
- 8. #Caturday 4,629 posts
- 9. #SaturdayVibes 5,138 posts
- 10. Todd Snider N/A
- 11. Virginia Tech 2,301 posts
- 12. Brooklynn 3,471 posts
- 13. James Borrego 1,643 posts
- 14. Draymond 30.2K posts
- 15. Marjorie 111K posts
- 16. PONDPHUWIN AT MAT PREMIERE 827K posts
- 17. Senior Day 2,628 posts
- 18. Lindsey Graham 20.4K posts
- 19. James Franklin 2,033 posts
- 20. Tony Dorsett N/A